|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Tanezumab>> Market Analysis Reports |
Market Analysis Reports of Tanezumab |
|
Tanezumab (CAS 880266-57-9) Market Research Report 2026 '@aboutTanezumab is a monoclonal antibody against nerve growth factor (NGF), with a molecular formula of C6464H9942N1706O2026S46. It was developed by the American corporation Pfizer as a pain mediator. Tanezumab is used to reduce pain in joints and ... Global Market Report of Tanezumab (CAS 880266-57-9) December 2024 |